2-STEP MODEL OF LEUKOCYTE ENDOTHELIAL-CELL INTERACTION IN INFLAMMATION - DISTINCT ROLES FOR LECAM-1 AND THE LEUKOCYTE BETA-2 INTEGRINS INVIVO

The lectin homing receptor LECAM-1 (LAM-1, Leu8) and the beta-2 integrins, particularly Mac-I (CD11b/CD18), participate in leukocyte-endothelial cell interactions in inflammation. LECAM-1 is rapidly shed while Mac-I expression is dramatically increased upon neutrophil activation, suggesting functionally distinct roles for these molecules. Using intravital video microscopy, we have compared the effect of antibodies against LECAM-1 and CD18 on leukocyte interactions with rabbit mesenteric venules. Anti-LECAM-1 monoclonal antibody and its Fab fragments inhibited initial reversible leukocyte rolling along the vascular wall. Anti-CD18 monoclonal antibody had no effect on rolling but prevented subsequent firm attachment of leukocytes to venular endothelium. These results support a two-step model of leukocyte-endothelial cell interactions: reversible rolling mediated in part by LECAM-1 facilitates leukocyte recruitment by the local microenvironment and precedes activation-dependent firm attachment involving beta-2 integrins.